A Phase 3, Double Blind, Placebo Controlled Trial and Long Term Safety Extension of Obeticholic Acid in Patients with Primary Biliary Cirrhosis
A Phase 3, Open-Label Study Evaluating the Efficacy and Safety of Liprotamase in Subjects with Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency.
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined with
Bevacizumab vs. Bevacizumab Monotherapy in Patients with Recurrent Glioblastoma
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Ivacaftor and VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation, and a Second Allele With a CFTR Mutation Predicted to Have Residual Function
A Phase 3/4, Multi-Center, Randomized, Double-Blind,
Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab
(HGS1006) in Adult Subjects of Black Race with Systemic Lupus Erythematosus (SLE).
A Phase I Therapeutic Dose Escalation Study using Percutaneous Image-Guided Navigation for High Dose Rate Brachyablation of Primary Liver Lesions
A Phase II Open-label, Multicenter Extension Study to Assess the Long-term Safety and Efficacy of Vamorolone in Boys with Duchenne Muscular Dystrophy (DMD)
A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors
A Phase II Trial of Rituximab In Myasthenia Gravis (NN103)